US Stock MarketDetailed Quotes
SBFM Sunshine Biopharma
- 2.3450
- -0.2250-8.75%
Close Nov 15 16:00 ET
- 2.3018
- -0.0432-1.84%
Post 20:01 ET
4.69MMarket Cap-18P/E (TTM)
2.6600High2.2500Low311.44KVolume2.5600Open2.5700Pre Close763.77KTurnover15.59%Turnover RatioLossP/E (Static)2.00MShares637.200052wk High0.19P/B4.68MFloat Cap2.250052wk Low--Dividend TTM2.00MShs Float125600.0000Historical High--Div YieldTTM15.95%Amplitude2.2500Historical Low2.4520Avg Price1Lot Size
About Sunshine Biopharma Company
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Fort Lauderdale, FL.
Company Profile
SymbolSBFM
Company NameSunshine Biopharma
Listing DateFeb 15, 2022
Founded2006
CEODr. Steve N. Slilaty, PhD
MarketNASDAQ
Employees44
Fiscal Year Ends12-31
Address333 Las Olas Way,CU4 Suite 433
CityFort Lauderdale
ProvinceFlorida
CountryUnited States of America
Zip Code33301
Phone1-945-515-0810
Company Executives
- Name
- Position
- Salary
- Dr. Steve N. Slilaty, PhD
- President and Chairman of the Board; Chief Executive Officer of the Company and Nora Pharma Inc
- 560.00K
- Camille Sebaaly
- Principal Accounting Officer, Chief Financial Officer and Secretary
- 695.00K
- Marc Beaudoin
- Chief Operating Officer
- --
- Malek Chamoun, C.P.A.
- Chief Development Officer
- --
- Dr. Abderrazzak Merzouki, PhD
- Chief Science Officer and Director
- 260.00K
- Dr. Andrew Keller, PhD
- Independent Director
- 80.00K
- Dr. Rabi Kiderchah, PhD
- Independent Director
- 80.00K
- David Natan
- Independent Director
- 80.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data